Quality Control and Risk Management of Carbon Nanomaterials

Our atmosphere contains a substantial number of nanoparticles in which some are unintentionally produced, whereas others are intentionally produced engineered nanoparticle. Among all ENPs, the single-walled and multi-walled carbon nanotubes, spherical fullerenes, and dendrimers are attracting attention for biomedical applications, such as biosensor design, drug delivery, tumor therapy, and tissue engineering. Because of the inert nature of pristine carbon nanotubes (CNTs), it needs to be functionalized to make it reactive with other organic and inorganic materials. The functionalization leads to the addition of functional groups, e.g., C ‖ O, C ▬ O, ▬ OH, and ▬ COOH, to CNTs, which make them dispersible in solvents and suitable for numerous applications. Functionalized CNTs and their composite need to be tested for biocompatibility before real-time applications. Various toxicity mechanisms have been suggested for CNTs, including interference of transmembrane electron transfer, interruption/penetration of the cell envelope, oxidation of cell elements, and formu-lation of secondary products such as dissolved heavy metal ions or reactive oxygen species (ROS). Numerous studies have insinuated that well-functionalized CNTs are innoxious to animal cells, while raw CNTs or CNTs without functionalization mani-fest toxicity to cells at even modest dosage. Further of of